SUMO1 · Western blot design guide

SUMO1 Western Blot Planning Guide

Plan a SUMO1 Western blot around the catalog-observed 11.6 kDa band, image-backed PA2220 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for SUMO1 (SUMO1): expected band 11.6 kDa, antibody PA2220, and guide-derived SDS-PAGE protocol steps
SUMO1 Western blot protocol sheet — expected band 11.6 kDa, antibody PA2220, controls and PMC citations. Open the full SUMO1 WB guide →

SUMO1 Western Blot Experimental Design Guide

Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 11.6 kDa
Observed band Not reported — verify product WB image
Gel 15%
Positive control ⓘ Adrenal gland
Negative control ⓘ Soft tissue
Important caveats
Reasons your observed band may differ from the expected size.
ⓘ Calculated mass 11.6 kDa
ⓘ Localization Nucleus membrane / Nucleus speckle
ⓘ Processing / PTM Record-dependent
ⓘ Reactivity Rat / Mouse / Human
Section 1

Real Curated SUMO1 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdipose tissue
Gel %15%
Load20-30 µg total protein per lane
TransferSemi-dry, short transfer
Membrane0.2 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryPA2220 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected SUMO1 Western Blot Band Size?

Use the product-observed 11.6 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
11.6 kDaMatches the authoritative product WB observation.
11.6 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected SUMO1 appearancePlan around 11.6 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band11.6 kDa; use this as the primary experimental expectation.
Calculated mass11.6 kDa from UniProt P63165; retain as context.
Gel selection15%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with PA2220.
Why is my band missing or off?
SituationLikely causeNext action
11.6 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for SUMO1 Western blot

🧪Use Adrenal gland as the first positive-control candidate and Soft tissue as the HPA Not detected negative candidate.
Positive control: Adrenal gland (High)
Negative control: Soft tissue (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for SUMO1

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Positive expression · recommended positive controls

TissueCell typeLevelEvidenceSource
Adrenal gland Reported tissue cells High Protein (HPA) HPA →
Breast Reported tissue cells High Protein (HPA) HPA →
Adipose tissue Reported tissue cells High Protein (HPA) HPA →
Bone marrow Reported tissue cells High Protein (HPA) HPA →

Undetected expression · recommended negative controls

TissueCell typeLevelEvidenceSource
Soft tissue Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced SUMO1 Western Blot Tips

Deeper troubleshooting and optimisation questions for SUMO1, answered from its protein features.

Which band should guide the blot?
Use 11.6 kDa, the observation attached to the authoritative PA2220 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 11.6 kDa expectation.
Which positive control should I start with?
Start with Adrenal gland, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Soft tissue as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for SUMO1 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PA2220 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

SUMO1 Western Blot Reagents

Rat/Mouse/Human-reactive SUMO1 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for SUMO1 using PA2220; observed band 11.6 kDa
Anti-Sumo 1/SUMO1 Antibody Picoband®
Cat # PA2220

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.

References

  1. UniProt P63165
  2. Human Protein Atlas — SUMO1
  3. PA2220 product record
  4. PMC3797200 — Estradiol potentiates 8-OH-DPAT-induced sumoylation of 5-HT₁A receptor: characterization and subcellular distribution of sumoylated 5-HT₁A receptors (Psychoneuroendocrinology, 2013)
  5. PMC7527722 — Klebsiella pneumoniae Reduces SUMOylation To Limit Host Defense Responses (mBio, 2020)
  6. PMC2034454 — Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation (Nucleic acids research, 2007)